118 related articles for article (PubMed ID: 32155620)
1. Primary Care of Opioid use Disorder: The End of "the French Model"?
Dupouy J; Maumus-Robert S; Mansiaux Y; Pariente A; Lapeyre-Mestre M
Eur Addict Res; 2020; 26(6):346-354. PubMed ID: 32155620
[TBL] [Abstract][Full Text] [Related]
2. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network.
Lépine B; Debin M; Dassieu L; Gimenez L; Palmaro A; Ponté C; Swital M; Lapeyre-Mestre M; Blanchon T; Dupouy J
J Subst Abuse Treat; 2022 Dec; 143():108891. PubMed ID: 36215914
[TBL] [Abstract][Full Text] [Related]
3. Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine.
Gimenez L; Bonis D; Morel M; Palmaro A; Dassieu L; Dupouy J
J Subst Use Addict Treat; 2024 Jan; 156():209182. PubMed ID: 37858793
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine prescription by general practitioners in a French region.
Thirion X; Lapierre V; Micallef J; Ronflé E; Masut A; Pradel V; Coudert C; Mabriez JC; Sanmarco JL
Drug Alcohol Depend; 2002 Jan; 65(2):197-204. PubMed ID: 11772481
[TBL] [Abstract][Full Text] [Related]
5. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
6. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
[TBL] [Abstract][Full Text] [Related]
7. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
8. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
9. Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists.
Hill LG; Light AE; Green TC; Burns AL; Sanaty Zadeh P; Freeman PR
J Am Pharm Assoc (2003); 2023; 63(1):252-260.e6. PubMed ID: 36202711
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
11. GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network.
Lépine B; Debin M; Dassieu L; Gimenez L; Palmaro A; Ponté C; Swital M; Lapeyre-Mestre M; Blanchon T; Dupouy J
Therapie; 2024 Apr; ():. PubMed ID: 38729825
[TBL] [Abstract][Full Text] [Related]
12. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
[TBL] [Abstract][Full Text] [Related]
14. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
[TBL] [Abstract][Full Text] [Related]
15. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
Longman C; Lintzeris N; Temple-Smith M; Gilchrist G
Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929
[TBL] [Abstract][Full Text] [Related]
16. French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?
Feroni I; Peretti-Watel P; Paraponaris A; Masut A; Ronfle E; Mabriez JC; Obadia Y
J Addict Dis; 2005; 24(3):7-22. PubMed ID: 16186080
[TBL] [Abstract][Full Text] [Related]
17. Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance.
Mark TL; Hinde JM; Zarkin GA; Parish W; Kluckman M
J Subst Abuse Treat; 2020 Sep; 116():108062. PubMed ID: 32741503
[TBL] [Abstract][Full Text] [Related]
18. Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.
Ostrach B; Potter R; Wilson CG; Carpenter D
J Am Pharm Assoc (2003); 2022; 62(2):588-597.e2. PubMed ID: 34674965
[TBL] [Abstract][Full Text] [Related]
19. [Prescription of high dose buprenorphine by general practitioners].
Feroni I; Paraponaris A; Aubisson S; Bouhnik A; Masut A; Ronfle E; Coudert C; Mabriez JC;
Rev Epidemiol Sante Publique; 2004 Dec; 52(6):511-22. PubMed ID: 15741914
[TBL] [Abstract][Full Text] [Related]
20. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy.
Hines KL; Garofoli GK; Garofoli MP; Elswick BM; Winstanley EL
J Am Pharm Assoc (2003); 2020; 60(6):e205-e214. PubMed ID: 32800678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
